M&A Deal Summary |
|
|---|---|
| Date | 2023-12-12 |
| Target | Perspective Therapeutics - Radioactive Seed Assets |
| Sector | Life Science |
| Buyer(s) | GT Medical Technologies |
| Sellers(s) | Perspective Therapeutics |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2017 |
| Sector | Medical Products |
GT Medical Technologies is a medical device company with the corporate purpose of improving the lives of patients with brain tumors. GT Medical Technologies was founded in 2017 and is based in Tempe, Arizona.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1998 |
| Sector | Life Science |
| Employees | 138 |
| Revenue | 11M USD (2022) |
Perspective Therapeutics is a diversified medical technology and radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body. Perspective Therapeutics has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides. Perspective Therapeutics was founded in 1998 and is based in Seattle, Washington.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
